Systemic vasoconstrictor effects of oxygen administration in obliterative pulmonary vascular disorders
- 1 April 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (10) , 853-858
- https://doi.org/10.1016/0002-9149(86)90626-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Vasodilator Therapy for Primary Pulmonary HypertensionAnnals of Internal Medicine, 1985
- Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular diseaseJournal of the American College of Cardiology, 1984
- Vasodilators and Prostaglandin Inhibitors in Primary Pulmonary HypertensionAnnals of Internal Medicine, 1982
- Primary pulmonary hypertension: new approaches to therapyAmerican Heart Journal, 1980
- PROSTACYCLIN AND PROSTAGLANDIN E1 FOR SEVERE IDIOPATHIC PULMONARY ARTERY HYPERTENSIONThe Lancet, 1980
- Longterm Favorable Effect of Oxygen Administration on a Patient with Primary Pulmonary HypertensionChest, 1978
- Factors Contributing to the Reversible Pulmonary Hypertension of Patients with Acute Respiratory Failure Studied by Serial Observations during RecoveryCirculation Research, 1969
- EFFECTS OF OXYGEN BREATHING ON THE HEART RATE, BLOOD PRESSURE, AND CARDIAC INDEX OF NORMAL MEN—RESTING, WITH REACTIVE HYPEREMIA, AND AFTER ATROPINE*Journal of Clinical Investigation, 1962
- Hemodynamic responses to oxygen breathing in manJournal of Applied Physiology, 1962
- CLINICAL, PHYSIOLOGICAL, AND PATHOLOGICAL CONSIDERATIONS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSIONHeart, 1957